top of page

WHAT EXACTLY ARE WE TRYING TO SOLVE?

"Identifying the problem is the first step toward finding the solution. Without a clear understanding of the issue, any attempt to solve it is futile."

- Albert Einstein

​

​

PROBLEM

The severe progression of Diabetes Mellitus (DM) stands out as one of the most significant concerns for healthcare officials worldwide. Diabetic Retinopathy (DR) is a common complication associated with diabetes, particularly affecting individuals between the ages of 18 and 65.

​

As per the findings of the International Diabetes Federation (IDF) report, 35–60% of individuals suffering from DR possess a diabetes history. Globally, diabetic retinopathy accounts for five percent of all blindness and is the leading cause of blindness in people aged 15 to 64.

​

Due to the absence of ophthalmologists worldwide, insufficient health resources, and healthcare services, patients cannot get timely eye screening services. Current DR screening methods often require specialized equipment and trained personnel, making it challenging to provide accessible and affordable screening, particularly in resource-limited settings.

 

This lack of accessibility leads to delayed diagnosis and treatment, increasing the risk of vision impairment and blindness among patients with diabetes. .

image.png

IMPORTANCE OF SOLVING THIS PROBLEM

Solving this problem is crucial because of the growing global prevalence of diabetes and its associated complications, such as DR.

According to the World Health Organization, the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014, and this number is expected to continue increasing.

 

DR is a leading cause of preventable blindness worldwide, and early detection and treatment can significantly reduce the risk of vision loss.

 

By developing a portable and automated DR screening device, we can improve access to screening services, particularly in underserved communities and developing countries.

 

This will enable timely intervention, better management of the disease, and ultimately, preserve the vision and quality of life for millions of people with diabetes.

Click below to see what we designed to solve this problem.

bottom of page